Due to the efficacy of GLP-1 upon blood glucose regulation, DPP-4i has gradually become a new anti-diabetic drug for the treatment of type 2 diabetes mellitus (T2DM). This evidence concerns the gene GCG and type 2 diabetes mellitus.